Phacilitate: Early Adoption and Partnerships – The Secret to Commercialization Success?

Terumo’s Stuart Gibb, Ph.D., Scientific Strategy Lead at Terumo Blood and Cell Technologies, is joined by Nisha C. Durand, PhD, Principal Research Technologist at Mayo Clinic and Matthew M. Hewitt, B.A. Ph.D., Executive Director, Scientific Services Cell and Gene Therapy at Charles River.

Terumo’s Stuart Gibb, Ph.D., Scientific Strategy Lead at Terumo Blood and Cell Technologies, is joined by Nisha C. Durand, PhD, Principal Research Technologist at Mayo Clinic and Matthew M. Hewitt, B.A. Ph.D., Executive Director, Scientific Services Cell and Gene Therapy at Charles River.